{"id":336,"date":"2025-07-11T09:54:04","date_gmt":"2025-07-11T09:54:04","guid":{"rendered":"https:\/\/synonecapital.com\/?post_type=portfolio&#038;p=336"},"modified":"2025-07-12T08:13:20","modified_gmt":"2025-07-12T08:13:20","slug":"transformative-cell-processing-company","status":"publish","type":"portfolio","link":"https:\/\/synonecapital.com\/zh\/portfolio\/transformative-cell-processing-company\/","title":{"rendered":"Transformative Cell Processing Company"},"content":{"rendered":"\n<div class=\"wp-block-group is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 class=\"wp-block-heading\">About<\/h2>\n\n\n\n<p class=\"has-lead-font-size\">Founded in August 2022 as a spin-off from National Yang-Ming Chiao-Tung University, TCPC aims to mass-produce high-quality iPS cells. Leveraging Taiwan\u2019s semiconductor-scale manufacturing expertise and partnering with Kyoto University\u2019s CiRA Foundation, the company develops cost-effective and standardized cell production processes. In April 2023, TCPC signed a letter of intent with CiRA Foundation to accelerate industrial and clinical adoption of iPS cells in regenerative medicine.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><\/h2>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>About Founded in August 2022 as a spin-off from Nationa [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":356,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","format":"standard","meta":{"_vp_format_video_url":"","_vp_image_focal_point":[],"footnotes":""},"portfolio_category":[29],"portfolio_tag":[],"class_list":["post-336","portfolio","type-portfolio","status-publish","format-standard","has-post-thumbnail","hentry","portfolio_category-venture-capital"],"_links":{"self":[{"href":"https:\/\/synonecapital.com\/zh\/wp-json\/wp\/v2\/portfolio\/336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/synonecapital.com\/zh\/wp-json\/wp\/v2\/portfolio"}],"about":[{"href":"https:\/\/synonecapital.com\/zh\/wp-json\/wp\/v2\/types\/portfolio"}],"author":[{"embeddable":true,"href":"https:\/\/synonecapital.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/synonecapital.com\/zh\/wp-json\/wp\/v2\/comments?post=336"}],"version-history":[{"count":2,"href":"https:\/\/synonecapital.com\/zh\/wp-json\/wp\/v2\/portfolio\/336\/revisions"}],"predecessor-version":[{"id":374,"href":"https:\/\/synonecapital.com\/zh\/wp-json\/wp\/v2\/portfolio\/336\/revisions\/374"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/synonecapital.com\/zh\/wp-json\/wp\/v2\/media\/356"}],"wp:attachment":[{"href":"https:\/\/synonecapital.com\/zh\/wp-json\/wp\/v2\/media?parent=336"}],"wp:term":[{"taxonomy":"portfolio_category","embeddable":true,"href":"https:\/\/synonecapital.com\/zh\/wp-json\/wp\/v2\/portfolio_category?post=336"},{"taxonomy":"portfolio_tag","embeddable":true,"href":"https:\/\/synonecapital.com\/zh\/wp-json\/wp\/v2\/portfolio_tag?post=336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}